2011 achievements and 2012 prospects - BioAlliance Pharma confirms the dynamics of its core business (PDF - 360 Ko)
BioAlliance Pharma announces two key steps with its AMEP™ biotherapy for metastatic melanoma (PDF - 385 Ko)
